Association of BRAF mutation with occult central neck lymph node metastases (Joo et al., 2012) might support use of BRAF mutation as an indication for prophylactic central neck dissection for patients with conventionally low- to intermediate-risk papillary thyroid cancer. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.